Range Low Price High Price Comment
30 days $14.60 $14.60 Friday, 27th May 2022 ADRO stock ended at $14.60. During the day the stock fluctuated 0% from a day low at $14.60 to a day high of $14.60.
90 days $14.60 $14.60
52 weeks $14.60 $14.60

Historical Aduro Biotech prices

Date Open High Low Close Volume
2019-08-19 $1.39 $1.42 $1.36 $1.37 151 266
2019-08-16 $1.35 $1.41 $1.35 $1.38 280 322
2019-08-15 $1.31 $1.38 $1.29 $1.35 186 300
2019-08-14 $1.32 $1.45 $1.27 $1.29 465 658
2019-08-13 $1.38 $1.43 $1.25 $1.32 2 023 866
2019-08-12 $1.32 $1.41 $1.31 $1.37 147 227
2019-08-09 $1.36 $1.40 $1.32 $1.32 431 090
2019-08-08 $1.34 $1.43 $1.32 $1.38 386 713
2019-08-07 $1.30 $1.36 $1.28 $1.32 220 456
2019-08-06 $1.29 $1.31 $1.22 $1.28 283 371
2019-08-05 $1.33 $1.35 $1.25 $1.26 330 366
2019-08-02 $1.37 $1.40 $1.35 $1.35 341 152
2019-08-01 $1.34 $1.44 $1.31 $1.40 354 149
2019-07-31 $1.37 $1.41 $1.32 $1.32 301 166
2019-07-30 $1.31 $1.42 $1.31 $1.37 335 206
2019-07-29 $1.35 $1.41 $1.31 $1.33 183 898
2019-07-26 $1.28 $1.39 $1.28 $1.36 549 130
2019-07-25 $1.33 $1.35 $1.25 $1.27 378 303
2019-07-24 $1.38 $1.38 $1.31 $1.32 334 243
2019-07-23 $1.35 $1.42 $1.30 $1.37 884 828
2019-07-22 $1.40 $1.40 $1.32 $1.33 343 227
2019-07-19 $1.46 $1.51 $1.41 $1.42 358 928
2019-07-18 $1.46 $1.52 $1.45 $1.47 212 442
2019-07-17 $1.49 $1.51 $1.44 $1.47 284 993
2019-07-16 $1.53 $1.56 $1.49 $1.49 276 823
Click to get the best stock tips daily for free!

About Aduro Biotech

Aduro Biotech Aduro BioTech, Inc., a clinical-stage immunotherapy company, focuses on the discovery, development, and commercialization that transform the treatment of challenging diseases. Its lead product candidate is CRS-207, an immuno-oncology therapy, which is in a Phase IIb clinical trial for the treatment of metastatic pancreatic cancer, unresectable malignant pleural mesothelioma, and ovarian cancer. The company also offers STING Pathway Activator prod... ADRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT